- Corrigendum: Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-related Symptoms
-
Lopez-Alvarenga JC, Sobrino-Cossio S, Fass R, Vargas-Romero JA
- KMID: 2325896
- J Neurogastroenterol Motil.
- 2012 Apr;18(2):232-232.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-Related Symptoms
-
Lopez-Alvarenga JC, Sobrino-Cossio S, Fass R, Vargas-Romero JA
- KMID: 2325839
- J Neurogastroenterol Motil.
- 2011 Oct;17(4):381-386.
BACKGROUND/AIMS: Gastroesophageal reflux disease is a highly prevalent disease. Assessing treatment efficacy is critical in that clinical endpoints are properly evaluated. Clinical tools for symptoms severity assessment should be discriminative,... -
- CITED
-
- Close
- SHARE
-
- Close
- Relief of Night-time Symptoms Associated With Gastroesophageal Reflux Disease Following 4 Weeks of Treatment With Pantoprazole Magnesium: The Mexican Gastroesophageal Reflux Disease Working Group
-
Lopez-Alvarenga JC, Orr W, Vargas-Romero JA, Remes-Troche JM, Morales-Arambula M, Soto-Perez JC, Mateos-Perez G, Sobrino-Cossio S, Teramoto-Matsubara O, Lopez-Colombo A, Orozco-Gamiz A, Saez-Rios , Arellano-Plancarte A, Chiu-Ugalde J, Tholen A, Horbach S, Lundberg L, Fass R
- KMID: 2381150
- J Neurogastroenterol Motil.
- 2014 Jan;20(1):64-73.
BACKGROUND/AIMS: To evaluate the effectiveness of pantoprazole magnesium (pantoprazole-Mg) 40 mg in the relief of esophageal and extra-esophageal symptoms of gastroesophageal reflux disease (GERD), particularly night-time symptoms. METHODS: Patients (aged 18-50... -
- CITED
-
- Close
- SHARE
-
- Close
